Companion diagnostics is categorized by rising requirement for improved personalized patient treatment that contributes healthcare providers and their patients and assurance about the treatment result in a positive way, differing from traditional treatment procedure.
The Global Companion Diagnostics Market was worth $3.34 billion in 2016 and estimated to be growing at a CAGR of 21.6%, to reach $8.88 billion by 2021
According to the report Global Companion Diagnostics Market published by Market Data Forecast, the global market is projected to reach USD 8.88 billion by 2021, at a CAGR of 21.6% from 2016 to 2021.
